Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease (Q24234935)

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Azathioprine has a very limited role in the treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

The clinical pharmacology of 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Azathioprine in the treatment of children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

6-Mercaptopurine Therapy in Selected Cases of Corticosteroid-Dependent Crohn's Disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Azathioprine for Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Further experience with azathioprine for Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Controlled trial of azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Controlled trial of azathioprine in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Place of azathioprine for Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Azathioprine: an adjunct to surgical therapy of granulomatous enteritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Dangers of immunosuppressive drugs in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

A controlled double blind study of azathioprine in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

A dose-ranging study of azathioprine pharmacokinetics after single-dose administration of a delayed-release oral formulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Long-term immunosuppressive treatment in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB3

1 reference

7 January 2021